Abstract:The Wnt/β - catenin signaling pathway plays numerous essential roles in animal development and tissue/stem cell maintenance. The activation of genes regulated by Wnt/β - catenin signaling requires the nuclear accumulation of β-catenin, a transcriptional co-activator. β-catenin is recruited to many Wnt-regulated enhancers through direct binding to T-cell factor/lymphoid enhancer factor (TCF/LEF) family transcription factors. β-catenin has previously been reported to form phase-separated biomolecular condensates (BMCs), which was implicated as a component of β-catenin's mechanism of action. This function required aromatic amino acid residues in the intrinsically disordered regions (IDRs) at the N- and C-termini of the protein. In this report, we further explore a role for β-catenin BMCs in Wnt target gene regulation. We find that β-catenin BMCs are miscible with LEF1 BMCs in vitro and in cultured cells. We characterized a panel of β-catenin mutants with different combinations of aromatic residue mutations in human cell culture and Drosophila melanogaster . Our data support a model in which aromatic residues across both IDRs contribute to BMC formation and signaling activity. Although different Wnt targets have different sensitivities to loss of β-catenin's aromatic residues, the activation of every target examined was compromised by aromatic substitution. These mutants are not defective in nuclear import or co-immunoprecipitation with several β-catenin binding partners. In addition, residues in the N-terminal IDR with no previously known role in signaling are clearly required for the activation of various Wnt readouts. Consistent with this, deletion of the N-terminal IDR results in a loss of signaling activity, which can be rescued by the addition of heterologous IDRs enriched in aromatic residues. Overall, our work supports a model in which the ability of β-catenin to form biomolecular condensates in the nucleus is tightly linked to its function as a transcriptional co-regulator.

Crystal Structure of a β-Catenin/Tcf Complex

Structure of a human Tcf4–β-catenin complex

[Crosstalk Between Canonical TGF-β/Smad and Wnt/β-catenin Signaling Pathway].

Crystal structure of a β-catenin/Axin complex suggests a mechanism for the β-catenin destruction complex

Crystal Structure of a Full-Length β-Catenin

Development of Structure-Based Pharmacophore to Target the Β-Catenin-tcf Protein–protein Interaction

Wnt target gene activation requires β-catenin separation into biomolecular condensates

Β-Trcp Couples Β-Catenin Phosphorylation-Degradation and Regulates Xenopus Axis Formation

Molecular regulation and pharmacological targeting of the β-catenin destruction complex

XTcf-3 Transcription Factor Mediates β-Catenin-Induced Axis Formation in Xenopus Embryos

Wnt signaling alters CTCF binding patterns and global chromatin structure

Wnt/β‐catenin signaling: Structure, assembly and endocytosis of the signalosome

Direct Targeting of -Catenin in the Wnt Signaling Pathway: Current Progress and Perspectives

Wnt-independent Beta-Catenin Transactivation in Tumor Development.

Structural Basis of β-Catenin Recognition by Tax-interacting Protein-1

Wnt/β-catenin Singal Transduction Pathway and Colorectal Cancer

Structure-based discovery of a novel inhibitor targeting the β-catenin/Tcf4 interaction.

Targeting the β-catenin signaling for cancer therapy

Modulation Of Beta-Catenin Signaling By The Inhibitors Of Map Kinase, Tyrosine Kinase, And Pi3-Kinase Pathways

Structural basis of beta-catenin recognition by Tax-interacting protein-1.

Medicinal Chemistry Strategies for the Development of Inhibitors Disrupting β-Catenin's Interactions with Its Nuclear Partners